Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modeling in Therapy01:26

Modeling in Therapy

823
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
823

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-genotoxic transplantation and in vivo selection through epitope editing.

Nature·2026
Same author

Optimized lentivirus-derived virus-like particles for efficient delivery of Cas9-based genome editors.

Nucleic acids research·2026
Same author

Clinical outcomes of lentiviral vector gene therapy for sickle cell disease.

Blood advances·2026
Same author

Development of a Novel Method to Detect AAV Vector Integration.

Viruses·2026
Same author

Transduction of Quiescent Human Hematopoietic Stem and Progenitor Cells Using Lentiviral Vectors and Virus-Like Particles.

Current protocols·2026
Same author

Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency.

The New England journal of medicine·2025

Related Experiment Video

Updated: May 5, 2026

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
15:04

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols

Published on: May 20, 2016

10.0K

Modeling integration site data for safety assessment with MELISSA.

Tsai-Yu Lin1, Giacomo Ceoldo2, Kimberley House1

  • 1National Gene Vector Biorepository, Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.

Nature Communications
|August 23, 2025
PubMed
Summary

We developed MELISSA, a statistical tool to analyze gene therapy integration sites and assess safety risks. This method identifies genes affecting clone growth, aiding the development of safer cell and gene therapies.

More Related Videos

Integrating Remote Sensing with Species Distribution Models; Mapping Tamarisk Invasions Using the Software for Assisted Habitat Modeling SAHM
12:26

Integrating Remote Sensing with Species Distribution Models; Mapping Tamarisk Invasions Using the Software for Assisted Habitat Modeling SAHM

Published on: October 11, 2016

13.2K
Surrogate Model Development for Digital Experiments in Welding
09:17

Surrogate Model Development for Digital Experiments in Welding

Published on: March 28, 2025

1.9K

Related Experiment Videos

Last Updated: May 5, 2026

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols
15:04

Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols

Published on: May 20, 2016

10.0K
Integrating Remote Sensing with Species Distribution Models; Mapping Tamarisk Invasions Using the Software for Assisted Habitat Modeling SAHM
12:26

Integrating Remote Sensing with Species Distribution Models; Mapping Tamarisk Invasions Using the Software for Assisted Habitat Modeling SAHM

Published on: October 11, 2016

13.2K
Surrogate Model Development for Digital Experiments in Welding
09:17

Surrogate Model Development for Digital Experiments in Welding

Published on: March 28, 2025

1.9K

Area of Science:

  • Biotechnology
  • Genetics
  • Bioinformatics

Background:

  • Gene and cell therapies utilize viral vectors, raising safety concerns regarding insertional mutagenesis.
  • Understanding the impact of vector integration sites is crucial for assessing therapeutic safety and efficacy.

Purpose of the Study:

  • To introduce MELISSA, a novel statistical framework for analyzing integration site (IS) data.
  • To quantify gene-specific integration rates and their influence on clone fitness.
  • To evaluate insertional mutagenesis risk in gene and cell therapy applications.

Main Methods:

  • Developed MELISSA, a regression-based statistical framework for IS data analysis.
  • Characterized lentiviral vector IS profiles in Mesenchymal Stem Cells (MSCs) and Hematopoietic Stem and Progenitor Cells (HSPCs).
  • Applied MELISSA to published IS data from gene therapy clinical trials.

Main Results:

  • MELISSA successfully estimated gene-specific integration rates and their impact on clone fitness.
  • Identified known and novel genes influencing clone growth through vector integration.
  • Demonstrated MELISSA's capability in characterizing IS profiles across different cell types.

Conclusions:

  • MELISSA provides a quantitative tool to assess insertional mutagenesis risk in gene and cell therapies.
  • Facilitates bridging the gap between IS data and safety/efficacy evaluations.
  • Supports the generation of data packages for Investigational New Drug (IND) and Biologics License (BLA) applications.